Literature DB >> 16917401

Comparison between the combined analysis and the DeMeester Score to predict response to PPI therapy.

Inder Mainie1, Radu Tutuian, Donald O Castell.   

Abstract

BACKGROUND: Distal esophageal acid exposure can be quantified using the DeMeester score (DS) or percentage time pH<4. In addition to these parameters, symptom index (SI) is used to evaluate the association of symptoms and acid reflux. Combined analysis (CA) including the SI and percentage time pH<4 provides a more comprehensive interpretation of pH monitoring results. AIM: To assess whether using CA compared with DS is more accurate for interpretation of pH monitoring.
METHOD: pH studies from 450 patients (303 female; mean age 53; range 11 to 88) off therapy between July 2002 and October 2004 were analyzed. DS (normal<14.7), percentage time pH<4 (normal; upright<6.3%, recumbent<1.2%), and the SI (positive symptom if >/=50%) were calculated for each patient. Symptom responses to proton pump inhibitors (PPIs) were assessed in patients with discordant DS and CA.
RESULTS: Sixty-six patients were identified as having a normal DS and an abnormal CA. Forty-one (62%) patients had abnormal reflux according to the CA and 25 (38%) had normal reflux but a positive SI. Ten patients were lost to follow-up, 43 (84%) improved on and were currently taking a PPI and 8 (16%) found no benefit from taking a PPI. Five (9%) patients were never tried on a PPI and 3 were still symptomatic. Twenty-two (88%) patients with a positive SI and normal reflux were followed-up (3 never prescribed PPI) and 17 (90%) improved with a PPI.
CONCLUSIONS: Interpreting the results of pH monitoring based solely on the composition DS misses patients with an acid "sensitive esophagus," a group of patients who benefit from PPI therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16917401     DOI: 10.1097/00004836-200608000-00008

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Gastro-esophageal reflux induced cough with airway hyperresponsiveness.

Authors:  Li Yu; Xiang-Huai Xu; Qiang Chen; Si-Wei Liang; Han-Jing Lv; Zhong-Min Qiu
Journal:  Int J Clin Exp Med       Date:  2014-03-15

2.  Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough.

Authors:  Xiang-Huai Xu; Zhong-Min Yang; Qiang Chen; Li Yu; Si-Wei Liang; Han-Jing Lv; Zhong-Min Qiu
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

3.  Patient factors predictive of 24-h pH normalization following endoluminal gastroplication for GERD.

Authors:  Yashodhan S Khajanchee; Michael Ujiki; Christy M Dunst; Lee L Swanstrom
Journal:  Surg Endosc       Date:  2009-05-09       Impact factor: 4.584

4.  Changing etiological frequency of chronic cough in a tertiary hospital in Shanghai, China.

Authors:  Hongmei Ding; Xianghuai Xu; Siwan Wen; Yiming Yu; Jing Pan; Cuiqin Shi; Ran Dong; Zhongmin Qiu; Li Yu
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

5.  Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.

Authors:  Tasleem Arif; Qazi Masood; Jaswinder Singh; Iffat Hassan
Journal:  BMC Gastroenterol       Date:  2015-02-15       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.